BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25593497)

  • 21. Survival impact and predictive factors of axillary recurrence after sentinel biopsy.
    Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Charytansky H; Rouzier R; Daraï E; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Fraisse J; Dravet F; Chauvet MP; Goncalves A; Lambaudie E
    Eur J Cancer; 2016 May; 58():73-82. PubMed ID: 26971077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel node mapping and skip metastases in patients with early gastric cancer.
    Lee SE; Lee JH; Ryu KW; Cho SJ; Lee JY; Kim CG; Choi IJ; Kook MC; Nam BH; Park SR; Lee JS; Kim YW
    Ann Surg Oncol; 2009 Mar; 16(3):603-8. PubMed ID: 19127361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center.
    Macalindong SS; Kim KH; Nam BH; Ryu KW; Kubo N; Kim JY; Eom BW; Yoon HM; Kook MC; Choi IJ; Kim YW
    BMC Cancer; 2018 Jan; 18(1):73. PubMed ID: 29329569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficiency of micrometastasis by sentinel node navigation surgery using indocyanine green and infrared ray laparoscopy system for gastric cancer.
    Yano K; Nimura H; Mitsumori N; Takahashi N; Kashiwagi H; Yanaga K
    Gastric Cancer; 2012 Jul; 15(3):287-91. PubMed ID: 22041868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of sentinel node involvement in gastric cancer.
    Morita D; Tsuda H; Ichikura T; Kimura M; Aida S; Kosuda S; Inazawa J; Mochizuki H; Matsubara O
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1046-52. PubMed ID: 17632042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lymphatic mapping and sentinel lymph node biopsy in gastric cancer].
    Gretschel S; Bembenek A; Ulmer Ch; Hünerbein M; Markwardt J; Schneider U; Schlag PM
    Chirurg; 2003 Feb; 74(2):132-8. PubMed ID: 12599031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for metastasis to para-aortic lymph nodes in gastric cancer: a single institution study in China.
    Wang L; Liang H; Wang X; Li F; Ding X; Deng J
    J Surg Res; 2013 Jan; 179(1):54-9. PubMed ID: 23040213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study.
    Roukos DH; Lorenz M; Karakostas K; Paraschou P; Batsis C; Kappas AM
    Br J Cancer; 2001 Jun; 84(12):1602-9. PubMed ID: 11401312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Optimal nodal dissection for early gastric cancer].
    Miwa K
    Nihon Geka Gakkai Zasshi; 2001 Jun; 102(6):484-9. PubMed ID: 11436512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric carcinoma: stage migration by immunohistochemically detected lymph node micrometastases.
    Jeuck TL; Wittekind C
    Gastric Cancer; 2015 Jan; 18(1):100-8. PubMed ID: 24550066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical impact of micrometastasis of the lymph node in gastric cancer.
    Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Higashi H; Watanabe T; Aridome K; Hokita S; Aikou T
    Am Surg; 2003 Jul; 69(7):573-7. PubMed ID: 12889619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
    Ojima H; Araki K; Kato T; Okamura K; Manda R; Hirayama I; Hosouchi Y; Nishida Y; Kuwano H
    Anticancer Res; 2006; 26(2B):1385-90. PubMed ID: 16619548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal extent of lymph node dissection for T1 gastric cancer, with special reference to the distribution of micrometastasis, and accuracy of preoperative diagnosis for wall invasion.
    Kojima N; Yonemura Y; Bando E; Morimoto K; Kawamura T; Yun HY; Ito I; Kameya T; Hayashi I
    Hepatogastroenterology; 2008; 55(84):1112-7. PubMed ID: 18705341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Retrospective analysis of extended gastrectomy and lymphadenectomy in early gastric cancer patients].
    Huang BJ; Lu C; Xu HM; Xu YY; Chen JQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):221-5. PubMed ID: 17520378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of minimally invasive treatment for early gastric cancer.
    Hyung WJ; Cheong JH; Kim J; Chen J; Choi SH; Noh SH
    J Surg Oncol; 2004 Mar; 85(4):181-5; discussion 186. PubMed ID: 14991872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor Budding Is Independently Predictive for Lymph Node Involvement in Early Gastric Cancer.
    Gulluoglu M; Yegen G; Ozluk Y; Keskin M; Dogan S; Gundogdu G; Onder S; Balik E
    Int J Surg Pathol; 2015 Aug; 23(5):349-58. PubMed ID: 25911564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The feasibility of sentinel lymph node biopsy for gastric cancer: the experience from Serbia.
    Stojanovic D; Milenkovic SM; Mitrovic N; Marinkovic D; Stevanovic D; Radovanovic D
    J BUON; 2013; 18(1):162-8. PubMed ID: 23613402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer.
    Kim JH; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Lee JH; Kim YS
    J Surg Res; 2010 Aug; 162(2):177-83. PubMed ID: 20031164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.